Technical Analysis: If the support level will not be broken there might be an opportunity to go long. Fundamental Analysis: Gilead Was Approached by AstraZeneca About Potential Merger
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.